受慢性移植对宿主疾病影响的个体器官的治疗反应
Takanobu Morishita1, Paul J Martin2, Yoshihiro Inamoto1
1Department of Blood and Marrow Transplantation & Cellular Therapy, Fujita Health University School of Medicine, Toyoake 470-1192, Japan.
Cells
|February 25, 2025
概括
慢性移植对宿主疾病 (GVHD) 在移植后影响了许多人. 本综述分析了各器官对治疗的反应,以指导未来的慢性GVHD管理,并改善患者的治疗结果.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 慢性移植与宿主疾病 (GVHD) 影响30-70%的患者在异构造血细胞移植 (HCT) 后.
- 标准的皮质类固醇初始治疗对三分之一的患者来说是不够的,需要替代性全身疗法.
- 慢性GVHD目前的治疗决策通常依赖于医生的经验,而不是器官特异性反应数据.
研究的目的:
- 审查和总结慢性GVHD影响的个体器官的治疗应答率.
- 识别当前评估方法中的差异,并突出慢性GVHD管理中的未满足需求.
- 为优化慢性GVHD治疗决策提供基于证据的见解.
主要方法:
- 对20项研究进行系统审查,报告了特定器官的治疗反应率.
- 基于客观标准和患者报告结果的响应率分析.
- 评估数据解释的警告,并确定研究缺陷.
主要成果:
- 在NIH标准和皮肤硬化症患者报告的结果之间存在重大差异.
- 某些新型药物对慢性GVHD肺部参与的反应率很高.
- 数据综合显示了不同器官和治疗方法的响应率的变化.
结论:
- 器官特异性治疗反应数据可以为慢性GVHD的临床决策提供信息.
- 需要改进的测量工具,特别是在皮肤表现方面.
- 进一步研究肺部参与的新疗法是有必要的,以改善患者的治疗结果.
关键词:
在 axatilimab 中使用.目前还没有osudil.慢性移植对宿主疾病.身体外的光电场.伊布鲁丁尼布可以.关键词 全源性 造血细胞移植 细胞移植器官的反应器官的反应卢克索利提尼布 (Ruxolitinib) 是一种药物.更多相关视频
09:50Induction of Intestinal Graft-versus-host Disease and Its Mini-endoscopic Assessment in Live Mice
Published on: February 11, 2019
9.6K
18:48In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
Published on: August 12, 2017
14.1K
相关概念视频
01:40Cell-mediated Immune Responses
66.7K
Overview
66.7K
01:24Tissue Transplantation
330
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
330
01:22Bone Marrow Sampling and Transplants
274
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
274